Cargando…
Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate
The purpose of this report is to evaluate the efficacy and safety of combined intravitreal injection of bevacizumab and intravitreal triamcinolone acetonide (IVTA) for recurrent inflammatory choroidal neovascular membrane (CNVM). It was a prospective interventional study of a young female, who was a...
Autores principales: | Pai, Sivakami A, Hebri, Sudhira P, Lootah, Afra M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545134/ https://www.ncbi.nlm.nih.gov/pubmed/23202396 http://dx.doi.org/10.4103/0301-4738.103795 |
Ejemplares similares
-
The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
por: Kolomeyer, A. M., et al.
Publicado: (2011) -
Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease
por: Moreker, Mayur R, et al.
Publicado: (2007) -
Choroidal Excavation in Vogt-Koyanagi-Harada Disease
por: Hashida, Noriyasu, et al.
Publicado: (2014) -
Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Ranjan, Richa, et al.
Publicado: (2018) -
Comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Jain, Manish
Publicado: (2018)